NKILT Therapeutics at Cell 2026

Nov 12–13, 2026 London, UK ~800 attendees Website

NKILT Therapeutics takes part in 2 sessions at Cell 2026 in London. Its sessions centre on widening patient access to cell therapies and on the route from discovery to deliverable treatments. The specific topic is its off-the-shelf CIR technology, aimed at reaching more patients globally.

OrganizationCell 2026 Attendance
Biotech
Develops off-the-shelf engineered NK cell therapies for leukaemias and solid tumours.
Talk
Fri Nov 13
11:40am–12:05pm
Panel
Fri Nov 13
2:45pm–3:10pm
From Discovery To Deliverability: Building The Next Generation Of Cell & Gene Therapies
with AeirBio
Cell and gene therapy

Explore the full Cell 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full Cell 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from NKILT Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction